Company / Operating Income per Share
Nurix Therapeutics, Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.77
FY2025
5-year range
-$4.37 / -$0.57
FY2021-FY2025
Trend
+13.9%
vs FY2024
Sector context
#154 of 201
Health Care
What the data says
Nurix Therapeutics, Inc.'s operating income per share of $-3.77 is lower than 77% of companies in the Health Care sector (FY2025). Operating Income per Share returned to growth in FY2025 after 3 years of decline, reaching $-3.77.
Based on SEC 10-K filings.
-3.77 in FY2025.
Declined from $-3.29 to $-3.77 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 201This company -$3.77 Sector average -$3.23
▼
-16.4% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 13.9% year-over-year.
- Ranks #154 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.77 | +13.9% |
| FY2024 | -$4.37 | -33.0% |
| FY2023 | -$3.29 | -24.5% |
| FY2022 | -$2.64 | -361.3% |
| FY2021 | -$0.57 | +96.8% |
| FY2020 | -$18.07 | -167.6% |
| FY2019 | -$6.75 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026